Precision Business Insights has published a report on the global oncology biosimilars market, estimating its value at USD 36,848.3 Million in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 12.4% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of...

Rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is increasing the demand for biologic treatments. Biosimilars provide affordable treatment options for patients who require long-term therapies. This trend is contributing to the continuous expansion of the biosimilars market. The global Biosimilars Market is experiencing remarkable growth as healthcare...